U36-13707-55093
3 vaccinations
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 461 / IN
- Registered
- 2021-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-05
Dose 1 — Pfizer-BioNTech
-
2021-06-02
Dose 2 — Pfizer-BioNTech
-
2021-12-28
Registered in v-safe
-
2022-01-07
Dose 3 — Pfizer-BioNTech
- 2022-01-10
- 2022-01-11
-
2022-01-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-26
Survey response — day 14, dose 3MedDRA: Muscular weakness, Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sore throat, muscle weaknessMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-05 | Pfizer-BioNTech | No |
| 2 | 2021-06-02 | Pfizer-BioNTech | No |
| 3 | 2022-01-07 | Pfizer-BioNTech | No |
Free text
Release 11 — day 14, dose 3
Symptoms: Sore throat, muscle weakness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Muscular weakness | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release